Current Status of and Perspectives on Cervical Cancer Screening in Korea
Since the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular healt...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Pathologists & the Korean Society for Cytopathology
2019-07-01
|
Series: | Journal of Pathology and Translational Medicine |
Subjects: | |
Online Access: | http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdf |
_version_ | 1819038751315197952 |
---|---|
author | Sung-Chul Lim Chong Woo Yoo |
author_facet | Sung-Chul Lim Chong Woo Yoo |
author_sort | Sung-Chul Lim |
collection | DOAJ |
description | Since the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular health check-ups for industrial workers and their family members were introduced in 1988 and were performed as part of the National Cancer Screening Program in 1999. As a result, the incidence of cervical cancer in Korea has been steadily decreasing. However, about 800 cases of cervical cancer-related deaths are reported each year due to false-negative test results. Hence, new screening methods have been proposed. Liquid-based cytology (LBC) was introduced in 1996 to overcome the limitations of conventional Pap smears. Since then, other LBC methods have been developed and utilized, including the human papilloma virus test—a method with higher sensitivity that requires fewer screenings. In this study, we review current issues and future perspectives related to cervical cancer screening in Korea. |
first_indexed | 2024-12-21T08:42:17Z |
format | Article |
id | doaj.art-c7cfb1222d6445e98df4a6510115392c |
institution | Directory Open Access Journal |
issn | 2383-7837 2383-7845 |
language | English |
last_indexed | 2024-12-21T08:42:17Z |
publishDate | 2019-07-01 |
publisher | Korean Society of Pathologists & the Korean Society for Cytopathology |
record_format | Article |
series | Journal of Pathology and Translational Medicine |
spelling | doaj.art-c7cfb1222d6445e98df4a6510115392c2022-12-21T19:09:55ZengKorean Society of Pathologists & the Korean Society for CytopathologyJournal of Pathology and Translational Medicine2383-78372383-78452019-07-0153421021610.4132/jptm.2019.04.1116837Current Status of and Perspectives on Cervical Cancer Screening in KoreaSung-Chul LimChong Woo Yoo0 Center for Uterine Cancer and Department of Pathology, National Cancer Center, Goyang, KoreaSince the introduction of the Papanicolaou (Pap) smear system in 1943, cervicovaginal cytology has been used as a standard screening test for cervical cancer. The dissemination of this test contributed to reductions of the incidence and mortality of cervical cancer worldwide. In Korea, regular health check-ups for industrial workers and their family members were introduced in 1988 and were performed as part of the National Cancer Screening Program in 1999. As a result, the incidence of cervical cancer in Korea has been steadily decreasing. However, about 800 cases of cervical cancer-related deaths are reported each year due to false-negative test results. Hence, new screening methods have been proposed. Liquid-based cytology (LBC) was introduced in 1996 to overcome the limitations of conventional Pap smears. Since then, other LBC methods have been developed and utilized, including the human papilloma virus test—a method with higher sensitivity that requires fewer screenings. In this study, we review current issues and future perspectives related to cervical cancer screening in Korea.http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdfUterusCervix uteriNeoplasmsScreeningPapanicolaou testHuman papillomavirus DNA testsPerspectives |
spellingShingle | Sung-Chul Lim Chong Woo Yoo Current Status of and Perspectives on Cervical Cancer Screening in Korea Journal of Pathology and Translational Medicine Uterus Cervix uteri Neoplasms Screening Papanicolaou test Human papillomavirus DNA tests Perspectives |
title | Current Status of and Perspectives on Cervical Cancer Screening in Korea |
title_full | Current Status of and Perspectives on Cervical Cancer Screening in Korea |
title_fullStr | Current Status of and Perspectives on Cervical Cancer Screening in Korea |
title_full_unstemmed | Current Status of and Perspectives on Cervical Cancer Screening in Korea |
title_short | Current Status of and Perspectives on Cervical Cancer Screening in Korea |
title_sort | current status of and perspectives on cervical cancer screening in korea |
topic | Uterus Cervix uteri Neoplasms Screening Papanicolaou test Human papillomavirus DNA tests Perspectives |
url | http://www.jpatholtm.org/upload/pdf/jptm-2019-04-11.pdf |
work_keys_str_mv | AT sungchullim currentstatusofandperspectivesoncervicalcancerscreeninginkorea AT chongwooyoo currentstatusofandperspectivesoncervicalcancerscreeninginkorea |